Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep944 | Pituitary - Clinical | ECE2017

Acromegaly and cardiovascular risk

Biagetti Betina , Aulinas Anna , Lopez Natividad , Garcia-Fernandez Esther , Arnau-Vives Maria Jose , Ciudin Andrea , Obiols Gabriel , Dalama Belen , Mesa Jordi

Background: Acromegaly (ACRO) is associated with increased cardiovascular morbidity and mortality, however, there is no evidence of an increase in ischemic heart disease in these patients. We hypothesized that non-classical cardiovascular risk factors such as epicardial fat (EF), interventricular septum thickness (IST), carotid intima-media thickness (CIMT), may be increased in ACRO and contribute to this higher cardiovascular morbidity.Objective: To eva...

ea0041ep262 | Clinical case reports - Pituitary/Adrenal | ECE2016

Left adrenal Ectopic cushing syndrome even more challenging

Biagetti Betina , Simo Olga , Ortiz Angel , Iglesias Carmela , Dalama Belen , Obiols Gabriel , Castell-Conesa Joan , Gracia-Burillo Amparo , Caubet Enric , Mesa Jordi

Background: The Ectopic ACTH Syndromes (EAS) often associated with severe hypercortisolism are really a challenge.Case presentation: We report the case of a 48-year-old woman, newly diagnosed with hypertension, hypokalemia despite renin-angiotensin blockers intake, and complaints of intense fatigue, muscular weakness, and easy bruising, which worse in four months. EAS was biochemically confirmed, but two urinary catecholamines collection were negatives d...

ea0056p793 | Pituitary - Clinical | ECE2018

Non-classical factors of cardiovascular risk in acromegaly

Biagetti Betina , Aulinas Anna , Ferrer Roser , Obiols Gabriel , Ciudin Andrea , Dalama Belen , Lopez Natividad , Garcia-Fernandez Esther , Jose Arnau-Vives Maria , Mesa Jordi

Background: Acromegaly (ACRO) is associated with greater cardiovascular morbidity and mortality, however, this is not entirely explained by the increase in classic cardiovascular risk factors (CVRF). C-reactive protein, galectin 3, adiponectin, B-type natriuretic peptide (BNP), apolipoprotein E, interleukin-6 and echocardiographic variables such as epicardial fat (EF) and interventricular septum thickness (IST) have been suggested as non-classical CVRF in the general populatio...

ea0099p118 | Pituitary and Neuroendocrinology | ECE2024

Hyponatremia after COVID-19 is frequent in the first year and increases re-admissions

Biagetti Betina , Sanchez-Moltava Adrian , Puig-Perez Albert , Campos-Varela Isabel , Pilia Florencia , Anderssen-Nordahl Emilie , Gonzalez-Sans Didac , Miarons Marta , Simo Canonge Rafael

Background: Hyponatremia has been related to worse outcomes from COVID-19 infection during hospital admission. However, little is known about the incidence and prevalence of hyponatremia after discharge and the associated risk factors.Methods: Prospective observational 24-month follow-up study of patients admitted at a tertiary hospital during the first COVID-19 wave. Kaplan-Meier curves and Cox proportional hazard models were used to assess the main var...

ea0081p160 | Pituitary and Neuroendocrinology | ECE2022

Differences in pituitary apoplexy

Biagetti Betina , Isabel Sarria Estrada Silvana , Esteban Cordero-Asanza , Chaachou-Charradi Anas , Ng-Won Karelis , Cicuendez Lopez Ocana Marta , Hernandez-Hernandez Irene , Rojano Toimil Alba , Pilar Costa Forner M , Elena Martinez-Saez , Casteras Anna , Simo Canonge Rafael

Objective: Pituitary apoplexy (PA) is a rare, sometimes life-threatening clinical syndrome. However, some cases are subclinical (SPA), just revealed by MR performed during the follow-up of known pituitary adenomas or due to other conditions. Our aims were to describe the clinical characteristics and evolution of the patients with SPA compared with patients with acute PA (APA). We also compare the results of surgery vs conservative management in the APA group.<p class="abst...

ea0090rc6.3 | Rapid Communications 6: Endocrine-related Cancer | ECE2023

Efficacy and safety of temozolomide in the treatment of aggressive pituitary neuroendocrine tumours in Spain

Lamas Cristina , Remon Pablo , Soto-Moreno Alfonso , Fajardo-Montanana Carmen , Biagetti Betina , Guerrero Fernando , Castro Marta Araujo , Mora Mireia , Hanzu Felicia Alexandra , Iglesias Pedro , Garcia Centeno Rogelio , Camara-Gomez Rosa

Introduction: Current guidelines propose temozolomide (TMZ) as the first-line chemotherapy for aggressive pituitary neuroendocrine tumors (PitNETs), but no clinical trials have been conducted and clinical experience in this context is limited.Patients and methods: A retrospective study of patients with aggressive pitNETs treated with TMZ was conducted by the members of the Neuroendocrinology Working Area of the Spanish Society of Endocrinology and Nutrit...

ea0073aep490 | Pituitary and Neuroendocrinology | ECE2021

Third month MRI predicts macroprolactinoma reduction after cabergoline therapy

Biagetti Betina , Sarria-Estrada Silvana , Ng-Won Karelis , Martinez-Saez Elena , Casteras Anna , Cordero-Asanza Esteban , Irene Hernández-Hernández , Efrain Cordero-Vazquez. , Alba Rojano , Canonge Rafael Simo

BackgroundTranssphenoidal surgery is in general the preferred first-line treatment for patients with macroadenomas except for prolactinomas, which is mainly indicated when the treatment with dopamine agonists (DA) fails. However, in those patients resistant to DA (i.e. volume reduction ObjectiveTo identify predictors of DA resistance in order...

ea0099rc5.5 | Rapid Communications 5: Pituitary and Neuroendocrinology | Part I | ECE2024

CRH-stimulated oxytocin in patients with hypopituitarism and hypothalamic damage: A randomized, single-blind, crossover, placebo-controlled trial

Asla Roca Queralt , Garrido Sanchez Maite , Urgell Rull Eulalia , Terzan Molina Silvia , Santos Vives Alicia , Fernandez Miro Merce , Varghese Nimmy , Atila Cihan , Calabrese Anna , Biagetti Betina , Christ-Crain Mirjam , Eckert Anne , Webb Susan M , Lawson Elizabeth A , Aulinas Maso Ana

Introduction: Disruption of the hypothalamic/pituitary axes may lead to hypopituitarism. Anterior pituitary deficiencies (APD) and arginine-vasopressin deficiency (AVP-D) are well established and are treated with hormone replacement. Over the last decade, preliminary studies support the presence of an oxytocin (OXT)-deficient state that might be clinically relevant in patients with hypopituitarism and hypothalamic damage (HHD). Therefore, identifying a provocative test to diag...

ea0081p166 | Pituitary and Neuroendocrinology | ECE2022

Pasireotide imaging study: magnetic resonance imaging as a predictor of therapeutic response in acromegaly

Ruiz Sabina , Venegas Moreno Eva , Gil Joan , CAMARA ROSA , Biagetti Betina , Angeles Galvez Moreno Maria , Maraver Silvia , Gonzalez-Molero Inmaculada , Pico-Alfonso Antonio , Abellan Galiana Pablo , trincado pablo , Teresa Herrera Arranz Maria , Olvera Pilar , Xifra Villarroya Gemma , Bernabeu Ignacio , Azriel Mira Sharona , Garcia-GarciA-Doncel Lourdes , Jorda Mireia , Valassi Elena , Puig-Domingo Manel

Background: T2-weighted magnetic resonance imaging (MRI) signal has been recently linked with a better tumor response to pasireotide treatment in patients with acromegaly (ACRO). Our aim was to evaluate the prevalence of this radiological feature and its association to therapeutic outcomes in a large cohort of ACRO patients treated with pasireotide.Methods: A retrospective multicentre study was performed in 15 Spanish tertiary university hospitals includ...

ea0090p401 | Pituitary and Neuroendocrinology | ECE2023

Mortality in acromegaly diagnosed in the elderly in Spain is higher in women compared to the general Spanish population

Biagetti Betina , Iglesias Pedro , Villar Taibo Rocio , Dolores Moure Maria , Paja Fano Miguel , Araujo Castro Marta , Ares Blanco Jessica , Cristina Alvarez Escola Maria , Vicente Almudena , Alvarez Guivernau Elia , Novoa-Testa Iria , Cordido Carballido Fernando , Camara-Gomez Rosa , Lecumberri Beatriz , Garcia Gomez Carlos , Bernabeu Ignacio , Manjon Miguelez Laura , Gaztambide Sonia , Webb Susan , Luis Menendez Torre Edelmiro , Jose Diez Juan , Simo Canonge Rafael , Puig-Domingo Manel

Context: There is no data on mortality of acromegaly diagnosed in the elderly. Objective: To compare clinical characteristics, GH-related comorbidities, therapeutic approaches and mortality of patients diagnosed before or after 2010 and to assess overall mortality compared with the general Spanish population. Setting: Spanish tertiary care centers.Design, Patients, and Methods: Retrospective evaluation of 118...